Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
This profile was auto-generated from public COAs. Claim it to start uploading verified COAs directly — free forever.
What fraction of this lab's COAs report each test type. Real third-party labs typically run a consistent panel; sparse coverage on safety tests (endotoxin, sterility) is a common signal of HPLC-only purity work.
| Vendor | Peptide | Lot | Purity | Endo | Tested | |
|---|---|---|---|---|---|---|
| Peptide Partners | AOD-9604 | AO202605 | 99.94% | ✓ | — | View |
| Peptide Partners | GHK-Cu | CU202604 | 99.94% | ✓ | — | View |
| Peptide Partners | AOD-9604 | AO202605 | — | — | — | View |
| Peptide Partners |
| SS-31 |
| SS202601 |
| — |
| — |
| — |
| View |
| Reta One Labs | Retatrutide | RT300326 | 99.86% | ✓ | — | View |
| Reta One Labs | Retatrutide | RT300326 | 99.86% | ✓ | — | View |
| Peptide Partners | MOTS-c | MC202603 | 99.96% | ✓ | — | View |
| Peptide Partners | Cagrilintide | CG202603 | 99.91% | ✓ | — | View |
| Reta One Labs | Retatrutide | RT100326 | 99.81% | ✓ | — | View |
| Reta One Labs | Retatrutide | RT200326 | 99.83% | ✓ | — | View |
| Reta One Labs | Retatrutide | RT500326 | 99.89% | ✓ | — | View |
| Reta One Labs | Retatrutide | RT600326 | 99.88% | ✓ | — | View |
| Reta One Labs | GHK-Cu | GK1000426 | 99.86% | ✓ | — | View |
| Reta One Labs | GHK-Cu | GK1000426 | 99.86% | ✓ | — | View |
| Reta One Labs | Retatrutide | RT100326 | 99.81% | ✓ | — | View |
| Reta One Labs | Retatrutide | RT500326 | 99.89% | ✓ | — | View |
| Reta One Labs | Retatrutide | RT200326 | 99.83% | ✓ | — | View |
| Reta One Labs | Retatrutide | RT600326 | 99.88% | ✓ | — | View |
| Peptide Partners | AOD-9604 | AO202605 | — | — | 2026-04-21 | View |
| Peptide Partners | Cagrilintide | CG202603 | — | — | 2026-04-14 | View |
| Peptide Partners | Cagrilintide | CG202603 | — | ✓ | 2026-04-14 | View |
| Peptide Partners | MOTS-c | MC202603 | — | ✓ | 2026-04-04 | View |
| Peptide Partners | MOTS-c | MC202603 | — | — | 2026-04-04 | View |
| Peptide Partners | GHK-Cu | CU202604 | — | ✓ | 2026-04-03 | View |
| Peptide Partners | SS-31 | SS202601 | — | — | 2026-04-02 | View |
| Peptide Partners | Klow | KW202602 | — | — | 2026-04-01 | View |
| Peptide Partners | Sermorelin | SER202601 | 99.94% | ✓ | 2026-04-01 | View |
| Peptide Partners | Pinealon | PN202603 | 99.97% | ✓ | 2026-04-01 | View |
| Peptide Partners | Pinealon | PN202603 | — | ✓ | 2026-04-01 | View |
| Peptide Partners | Sermorelin | SER202601 | — | ✓ | 2026-04-01 | View |
| Peptide Partners | Pinealon | PN202603 | — | — | 2026-04-01 | View |
| Peptide Partners | CJC-1295 (No DAC)/Ipamorelin | CJIP202602 | — | — | 2026-04-01 | View |
| Peptide Partners | SS-31 | SS202602 | — | — | 2026-04-01 | View |
| Peptide Partners | Glow | GW202603 | — | — | 2026-04-01 | View |
| Peptide Partners | MOTS-c | MC202602 | — | — | 2026-04-01 | View |
| Peptide Partners | MOTS-c | MC202603 | — | — | 2026-04-01 | View |
| Peptide Partners | Cagrilintide | CG202603 | — | — | 2026-03-31 | View |
| Peptide Partners | Semax | SX202603 | — | ✓ | 2026-03-31 | View |
| Peptide Partners | Semax | SX202603 | 99.92% | ✓ | 2026-03-31 | View |
| Peptide Partners | Semax | SX202603 | — | — | 2026-03-31 | View |
| Peptide Partners | Sermorelin | SER202601 | — | — | 2026-03-29 | View |
| Peptide Partners | Tirzepatide | TZ202603 | — | — | 2026-03-26 | View |
| Peptide Partners | Glow | GW202603 | 99.89% | ✓ | 2026-03-25 | View |
| Peptide Partners | Glow Strength | GW202603 | — | ✓ | 2026-03-25 | View |
| Peptide Partners | Glow | GW202603 | — | — | 2026-03-24 | View |
| Peptide Partners | BPC-157 | BC202604 | — | — | 2026-03-17 | View |
| Peptide Partners | BPC-157 | BC202604 | — | ✓ | 2026-03-17 | View |
| Peptide Partners | Thymosin alpha-1 | TA202602 | — | — | 2026-02-25 | View |
| Peptide Partners | Thymosin alpha-1 | TA202602 | — | ✓ | 2026-02-25 | View |
| Peptide Partners | CJC-1295 (No DAC)/Ipamorelin | CJIP202602 | — | ✓ | 2026-02-25 | View |
Disclosed Labs